Value Strategy, in Context of Audience & Environment

Almost 60% of pharmaceutical companies cite “Market Access challenges” as their biggest barrier to successful launches.

So, how do we help develop winning launch strategies that drive accelerated patient access?

CDP Mentor is a global network of former Payers, KOLs, and trusted Advisors who share their insights to build strategies and help you navigate the path to access.

Empty space, drag to resize

Customer-Centric Strategy

Write your awesome label here.
Empty space, drag to resize

CDP Mentor Helps Define Value In Context of Audience & Environment

We believe a customer-centric strategy is the key to achieving optimal patient access and we’ve built a network of more than 700 Advisors who agree!

Our expert Clinical & Economic Advisors have worked for HTA Agencies at the National, Regional, and Local levels. Now, they help you align to the 5 key elements critical to addressing stakeholders' needs - in context of each audience and environment.

Stakeholder Insights & Validation

Patients' access to your therapies heavily depends on stakeholders' perceived clinical benefits and differentiation from other options. CDP will help identify the key decisions that influence adoption and use this to create project roadmaps that capitalize on your unique advantages.  
Write your awesome label here.

Develop Winning Go-to-Market Plans

High-performing launches happen when teams execute consistently across countries, regions, and local institutions. Make sure your entire cross-functional team knows the playbook, and their part in achieving the big picture goals.

Work With Advisors Who Know, From Experience.

Close the gap between technical knowledge, and applicable insights that drive adoption.

Our Expert Advisors Provide Guidance Across The Access Lifecycle

product & portfolio planning 
Business Development,
Licensing, Due Diligence
Landscape and Market Assessments
Go/No-go Decision Support
Indication Sequencing
Rare Diseases
Evidence generation planning
Clinical Trial Design
Economic Modelling
Clinical Outcomes Assessment Strategy
RWE Strategy
TPP Testing
Value Strategy & Narrative Testing
pricing & Reimbursement strategy
Willingness & Ability to Pay
Gross-to-Net Pricing
Value-based Agreements
Pricing & Reimbursement thresholds
Potential Pricing Scenarios
Policies & Pathways Research
Impact of IRA
EU Joint Clinical Assessments
Policy Impact
Bundling Submissions
Reactions to changes in Clinical
Guidelines

Define Value In Context Of Audience and Environment

Access & Adoption

  • Clinical vs. Non-Clinical Value Dynamics
  • Site of Care Reimbursement Archetypes and Drivers
  • Payer Coverage and Control Drivers
  • Competitive Activity
  • Impact of Clinical Pathways

Site of Care

  • Business Model Attributes
  • Patient Out of Pocket Costs
  • Coding Requirements and Barriers
  • Reimbursement Support
  • Relevance of Cost Recovery
  • Relevance of Contracting
  • Government Pricing Implications

Benefit Categories

  • Medical vs. Pharmacy Benefit
  • Outpatient vs. Inpatient
  • Provider vs. Payer Influence
  • Health Policy Trend Implications
  • Early indicators of shifts in behavioral drivers

Distribution

  • Specialty Distributors
  • Hospital and Full-Line Wholesaler
  • Specialty Pharmacy
  • In-Office Dispensing
  • Specialty and Hospital GPOs
  • 3PL

One Contract. Access Everything.

CDP Mentor offers a credit-based model that allows you to access our any of our workshops, or create custom engagements with our Advisors through:

  1. CDP Pronto: Quick 30+ minute calls over Zoom
  2. CDP Strategy: Advisor-led Strategy Sessions
  3. CDP Validate: Double-Blinded Research with 700+ Payers & KOLs
  4. CDP Focus: Peer-Moderated Virtual Ad Boards

Our Leadership Team

Nick DeJesus

President & Managing Partner,
 CDP Engage
Empty space, drag to resize
Nick has been a Customer Strategy & Stakeholder Engagement Advisor to more than 30 launch brands with a "value in context" approach.

He's managed more than 500 projects across Payer, Provider, and Patient engagement for Oncology, Virology, Neurology, Metabolic, Ophthalmology, Rare, Cell & Gene Therapies.


C
ontact Nick for details on CDP Engage or Roadmaps  @ ndejesus@cdpmentor.com

Nikos Georgiades, Ph.D

Chief Strategy Officer & Managing Partner,
CDP Strategy
Empty space, drag to resize
Nikos brings 20 years' experience as a global launch leader, focusing on biopharma commercialization, operations, data and digital technology.​​

His expertise spans late-stage development through post-launch commercialization and has led sales and marketing organizations, establishing global launch readiness capabilities across Novartis as well as McKinsey.

Contact Nikos for details on CDP Strategy or Roadmaps @ ngeorgiades@cdpmentor.com​

Jeff Greenhouse

Chief Operating Officer & Managing Partner,
Launch Academy
Empty space, drag to resize
Jeff is a Strategic Advisor to CEOs and Corporations with a focus on maximizing the value of their data and enabling their teams to pull actionable insights from it.

His 25 years' experience as an analytics executive, agency owner, entrepreneur and trainer have created data-driven value across numerous industries, from startups to global, public companie
s. 


Contact Jeff for details on Launch Academy

@ jgreenhouse@cdpmentor.com